Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switching from Generic Clozapine to FazaClo in Schizophrenia
NCT00501618Phase 4Completed
- Sponsor
- Manhattan Psychiatric Center
- Start
- Nov 2006
- Primary completion
- Mar 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of clozapine in schizophrenia, schizoaffective disorder, sponsored by Manhattan Psychiatric Center. Started Nov 2006; status: completed.
02
Drugs
clozapine
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00501618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00501618.